(Q46213246)

20 December 2017

title

Computer-based design of novel HIV-1 entry inhibitors: neomycin conjugated to arginine peptides at two specific sites (English)

1 reference

20 December 2017

author name string

Alexander Berchanski

series ordinal

1

1 reference

20 December 2017

Aviva Lapidot

series ordinal

2

1 reference

20 December 2017

publication date

5 December 2008

1 reference

20 December 2017

Journal of Molecular Modeling

published in

1 reference

20 December 2017

volume

15

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

281-294

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s00894-008-0401-1

exact match

0 references

cites work

Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates

1 reference

https://api.crossref.org/works/10.1007%2FS00894-008-0401-1

NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-008-0401-1

An overview of the determinants of CCR5 and CXCR4 co-receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-008-0401-1

The CD4-gp120 interaction and AIDS pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00894-008-0401-1

Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B

21 January 2018

1 reference

12 December 2020

Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.

1 reference

12 December 2020

Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities

1 reference

12 December 2020

Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques

1 reference

12 December 2020

Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor

1 reference

12 December 2020

Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies

1 reference

12 December 2020

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

1 reference

12 December 2020

Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events

1 reference

12 December 2020

Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf.

1 reference

12 December 2020

I want a new drug: G-protein-coupled receptors in drug development

1 reference

12 December 2020

Safe use of the CXCR4 inhibitor ALX40-4C in humans

1 reference

12 December 2020

Mutations in gp41 and gp120 of HIV-1 isolates resistant to hexa-arginine neomycin B conjugate.

1 reference

12 December 2020

Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure

1 reference

12 December 2020

Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion

1 reference

12 December 2020

Classical electrostatics in biology and chemistry

1 reference

12 December 2020

CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor

1 reference

12 December 2020

Structure of a V3-containing HIV-1 gp120 core

1 reference

12 December 2020

Hydrophobic complementarity in protein-protein docking

1 reference

12 December 2020

Polyarginine enters cells more efficiently than other polycationic homopolymers

1 reference

12 December 2020

Multi-targeting the entrance door to block HIV-1.

1 reference

12 December 2020

Prediction of protein-ligand interactions. Docking and scoring: successes and gaps

1 reference

12 December 2020

Prospects of HIV-1 entry inhibitors as novel therapeutics

1 reference

12 December 2020

The Amber biomolecular simulation programs

1 reference

12 December 2020

Focusing of electric fields in the active site of Cu-Zn superoxide dismutase: effects of ionic strength and amino-acid modification

1 reference

12 December 2020

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

12 December 2020

How will CCR5 antagonists influence the recommendations for the antiretroviral treatment of HIV-1 infection.

1 reference

12 December 2020

Docking and scoring in virtual screening for drug discovery: methods and applications

1 reference

12 December 2020

Localized changes in the gp120 envelope glycoprotein confer resistance to human immunodeficiency virus entry inhibitors BMS-806 and #155.

1 reference

12 December 2020

Recent progress in antiretrovirals--lessons from resistance

1 reference

12 December 2020

Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription

1 reference

12 December 2020

Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities

1 reference

12 December 2020

Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains

1 reference

12 December 2020

HIV-1 cell entry and advances in viral entry inhibitor therapy

1 reference

12 December 2020

Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists

1 reference

12 December 2020

CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates

1 reference

12 December 2020

The role of receptors in the HIV-1 entry process.

1 reference

12 December 2020

1 reference

12 December 2020

Electrostatics in protein-protein docking

1 reference

12 December 2020

Structure of an unliganded simian immunodeficiency virus gp120 core

1 reference

12 December 2020

Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins

1 reference

12 December 2020

Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography.

1 reference

12 December 2020

Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development.

1 reference

12 December 2020

Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery

1 reference

12 December 2020

10.1007/S00894-008-0401-1

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017